Savita K Chaudhry, MD | |
310 Sunnyview Ln, Kalispell, MT 59901-3129 | |
(406) 752-5111 | |
Not Available |
Full Name | Savita K Chaudhry |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Location | 310 Sunnyview Ln, Kalispell, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215960406 | NPI | - | NPPES |
0043784 | Medicaid | MT | |
1062892 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 6471 (Montana) | Primary |
207LP2900X | Anesthesiology - Pain Medicine | 6471 (Montana) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Savita K Chaudhry, MD Po Box 24823, Seattle, WA 98124-0823 Ph: (425) 407-1500 | Savita K Chaudhry, MD 310 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 752-5111 |
News Archive
Each cell in an organism has a sensor that measures the health of its "internal" environment. This "alarm" is found in the endoplasmic reticulum, which is able to sense cellular stress and trigger either rescue responses or the death of the cell.
A new study has found that uterine cancer cases are rising and that black women are 'twice as likely to die' from aggressive uterine cancer.
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.
If subway terminals didn't exist and people had to exit subway stations to switch subway lines, transit time would increase. People also may encounter distractions, such as grabbing a cup of coffee, instead of getting on the other line. Molecules also use "terminals" to save transit time during enzyme-catalyzed processes. Using advanced X-radiation techniques, University of Missouri researchers were able to visualize one of these terminals inside of an enzyme that degrades proline, which is an amino acid that has a central role in metabolism.
› Verified 3 days ago
Kenyon W Kruse, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Dr. Katherine W Holley, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Dr. Melanie Pittard, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 425-407-1500 | |
Dr. Andrew Francis Palmer, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Bradford L. Olson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Michael A. Sugarman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Kevin Jude Scholten, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 |